creatine kinase MM in blood; GSP Neonatal Creatine Kinase-MM kit

From Aaushi
Jump to navigation Jump to search

Indications

Clinical significance

Methods

Specimen

  • heel stick collected 24 to 48 hours after birth.

More general terms

Additional terms

References

  1. FDA News Release. December 12, 2019 FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-test-aid-newborn-screening-duchenne-muscular-dystrophy